Reference for medical professionals. Not a substitute for clinical judgment, institutional protocols, or peer-reviewed literature. Full disclaimer →
Imaging recommendation · Abdomen · Pelvis

Insulinoma — pre-operative localization imaging

Recommended: Multiphase pancreas-protocol CT or MRI is the preferred imaging study for insulinoma — pre-operative localization imaging. After biochemical confirmation (hypoglycemia + inappropriate insulin/C-peptide on 72-h fast).

Recommended study

Multiphase pancreas-protocol CT or MRI

CT IV contrast Preferred Abdomen · Pelvis Outpatient Reviewed

After biochemical confirmation (hypoglycemia + inappropriate insulin/C-peptide on 72-h fast). Insulinomas are typically small (< 2 cm) and hypervascular — multiphase pancreas CT (arterial + portal venous) or contrast-enhanced MRI with hepatobiliary phase. Endoscopic ultrasound (EUS) is highly sensitive for small lesions. DOTATATE PET-CT has variable sensitivity for insulinoma (lower somatostatin receptor density vs other NETs).

If the default doesn't apply

CT/MRI non-diagnostic — small lesion suspected
Endoscopic ultrasound (EUS) No contrast
Occult source despite EUS + CT/MRI
Selective intra-arterial calcium stimulation with hepatic venous sampling (IR) IV contrast
MEN1 — multifocal screening
MRI MRI pancreas + DOTATATE PET-CT IV contrast

Watch-outs

DOTATATE for insulinoma

Sensitivity is lower than for other pancreatic NETs (~50%) — don't rely on a negative DOTATATE to exclude insulinoma.

Multifocality in MEN1

Look for additional pancreatic NETs, parathyroid, pituitary lesions — screen the whole syndrome.

Pearls

  • Insulinomas: avidly arterial-enhancing, < 2 cm, distributed throughout pancreas.
  • Arterial-phase imaging is the highest-yield single phase for detection.
  • EUS sensitivity approaches 90% for head/body lesions, lower in the tail.
  • Surgical cure rate > 90% for solitary insulinoma — accurate localization is the whole point.
Tags